Zhuyin (Julie) Li
About Zhuyin (Julie) Li
Zhuyin (Julie) Li is the Scientific Director of High Content Screening (HCS) at Bristol-Myers Squibb, specializing in Lead Discovery & Optimization.
Title
Zhuyin (Julie) Li is the Scientific Director, High Content Screening (HCS), Lead Discovery & Optimization at Bristol-Myers Squibb.
Company
Zhuyin (Julie) Li currently holds the role of Scientific Director, High Content Screening (HCS), Lead Discovery & Optimization at Bristol-Myers Squibb in the Greater New York City Area.
Previous Positions
Zhuyin (Julie) Li's career includes significant roles at various institutions. She served as the Biology Team Leader at The National Institutes of Health from 2012 to 2014 in Rockville, MD. Prior to that, she was the Associate Director at Sanofi from 1998 to 2012 in Bridgewater, NJ, USA. From 1994 to 1998, she worked at Roche Diagnostics as Principal Scientist and R&D Manager.
Education and Expertise
Zhuyin (Julie) Li earned her Ph.D. in Biophysical Chemistry from the California Institute of Technology and her BS in Chemistry from Xiamen University. Her expertise includes high throughput, multiplexed, and quantitative bioimaging analysis for both cell-based and tissue-based HCS assays.
Current Responsibilities
In her current role at Bristol-Myers Squibb, Zhuyin (Julie) Li leads the Preclinical Translational Biomarker team to identify novel biomarkers for immuno-oncology, immunology, heart failure, and fibrosis indications. She also orchestrates the global High Content Screening (HCS) footprint at the company.